A B S T R A C T Evidence has been sought for a genetically determined predisposition among children with juvenile rheumatoid arthritis (JRA) who are also at particular risk for the development of inflammatory eye disease.
INTRODUCTION
Long-term evaluation of children with juvenile rheumatoid arthritis (JRA)l suggests that patients with this diagnosis comprise several groups with clinically important distinctions (1, 2) . The variables commonly used to define assignments to these clinical divisions include: sex, age of onset, extent ofjoint involvement, and the presence or absence of systemic features. The existence of several groups within the JRA population is to some extent reinforced by recent reports suggesting a complexity of human leukocyte antigen (HLA) associations in JRA populations (3, 4, 5) .
One group of children with JRA, comprising some 15% of the whole, share features sufficient to regard them as a relatively homogeneous population. These patients are predominantly female; have onset of their disease in the first 5 yr of life and whose joint involvement, at onset, is described as pauciarticular; that is, four or fewer joints are involved in the first 6 mo of the disease. Antinuclear antibodies are frequently found in the serum of these pauciarticular patients who are at particular risk for an inflammatory ocular complication, namely, iritis (6) . The iritis may be chronic with a significant risk of impairment in vision (7).
We report a study of HLA-A, -B, -C, and -DR polymorphisms in children with early-onset pauciarticular JRA and iritis, a search for evidence of an inherited predisposition.
METHODS
Subjects. 45 Caucasian patients (41 female and 4 male) with early-onset pauciarticular JRA were studied, 24 of whom developed iritis in addition to JRA. The majority of patients were involved in earlier reports (2, 8) and were only studied if meeting the definition of JRA as outlined by the JRA Criteria Committee of the American Rheumatism Association (9) . Pauciarticular onset arthritis was defined as disease involvement of four or less joints within the first 6 mo of the disease (9) . Age of onset was 5 yr or younger in 41 of the 45 patients. Length of follow-up at the Robert Breck Brigham Hospital JRA clinic ranged from 3.5 to 38 yr, with 28 patients having been followed for 10 yr or more. All patients were evaluated on an annual basis, on which occasion their work-up included an ophthalmological consultation and an assay for antinuclear antibody. Additional eye examinations were carried out as demanded by the clinical situation. Members of families of 11 HLA-A, -B, and -C typing. HLA-A, -B, and -C typing for 39 specificities was carried out by microdoplet complementdependent cytotoxicity (CDC) (10) . HLA-A, -B, and -C antisera were kindly supplied by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
HLA-DRw typing. HLA-D-related (DRw) specificities were typed by CDC on a B cell-enriched mononuclear leukocyte population (MNL). Enrichment of MNL for B lymphocytes was achieved by nylon wool column separation (nylon fiber, 30 denier type 200, Fenwal Laboratories, Deerfield, Ill.) (11) .
The nylon wool-adherent MNL obtained after 1 h 370C incubation have been shown to contain 60-84% surface IgMbearing lymphocytes. All preparations studied were evaluated (12) .
Typing antisera induced sera defined by the Seventh and Eighth International Histocompatibility Workshops (13, 14) covering eight DR specificities.
Antinuclear antibody (ANA). ANA in serum was detected by immunofluorescence as described (15) .
Statistical methods. Frequencies of HLA in patients and control groups were compared with the X2 test. The relative risk was calculated with the formula hK/Hk, where h and k represent the number of patients and controls, respectively, with a particular antigen and H and K the number without (16) .
Delta (A) represents an estimate of linkage disequilibrium for a given pair of genes and was derived as follows: A = pq -p'q', where pq is the observed frequency of a pair of genes p and q in the same individual and p'q' is the expected frequency of the combination of genes based on their individual frequencies in the population (17) .
RESULTS
HLA-D antigens. Two HLA-DRw antigens, DRw5 and DRw8 were found in increased frequency in the JRA population (Table I) 7 .0. HLA-DRw5 was found in 17 (71%) of the 24 patients with iritis as compared with controls (X2, 23.59, P = <0.001) and in 11 (52%) of the 21 (X2, 9.77, P = <0.01) who did not develop this complication. Of the 45 patients, 9 (20%) were typed as HLA-DRw8 (X2, 7.51, P = <0.01) compared with 4 (5%) of 84 controls, including 6 (25%) of the 24 with iritis (X2, 9.10, P = <0.01). The relative risk for HLA-DRw8 was 5.0. HLA-DRw7 was found less commonly than expected in the patient population (Table I) .
HLA-A, -B, and -C antigens. One HLA-B antigen, Bw35, was increased in the JRA population, being present in 14 of the 45 patients compared with 51 (18%) of 283 controls (X2, 4.19, P = <0.05) and was also present in 9 (37%) of 24 patients with iritis compared with 51 (18%) ofthe 283 controls (X2, 6.01, P = <0.05). No other HLA-A, -B, or -C antigens were found to an increased extent, and one patient only typed HLA-B27. Estimates of linkage disequilibrium (A) on the JRA population data gave a value of 0.090 between HLA-DRw5 and HLA-B12, a value of 0.070 between HLA-DRw5 and HLA-Cw4, and a value of 0.050 between HLA-DRw5 and HLA-Bw35.
HLA-A, -B, and -C haplotypes. Family studies allowed definition of 11 haplotypes carrying HLAJuvenile Rheumatoid Arthritis, HLA-DRw5, Iritis, and Antinuclear Antibody DRw5; in 6 of the haplotypes HLA-B12 was linked to HLA-DRw5 and HLA-Bw35 in three.
ANA. ANA was found in the serum of 15 (63%) of the 24 patients with iritis compared with 6 (28.5%) of 21 without the ocular complication (X2, 5.18, P = <0.05). 17 (62%) of the 28 patients typed as HLADRw5 were ANA positive compared with 4 (24%) ofthe 17 not so typed (X2, 7.03, P = <0.01). 12 (70%) of the 17 patients with both iritis and HLA-DRw5 had a positive ANA compared with one of 10 patients without either HLA-DRw5 or iritis (X2, 9.26, P = <0.01) ( Table II) . DISCUSSION Three antigens, HLA-DRw5, HLA-DRw8, and HLABw35, were found to be increased in frequency in these 45 patients with early-onset pauciarticular JRA. HLADRw5, an antigen without other reported rheumatic disease associations, was present in approximately twothirds of the patient population. The increase in HLABw35 in these 45 patients would appear secondary to that of HLA-DRw5 in view of the raised delta values for the linkage disequilibrium between these two antigens shown in this study. International Workshop studies (13) have shown that Cw4 to be in linkage disequilibrium with HLA-Bw35, so that the increase in delta for HLA-DRw5 and HLA-Cw4 reinforces the view that, in these pauciarticular JRA patients, HLADRw5, HLA-Bw35, and HLA-Cw4 form a group of genes in linkage disequilibrium. HLA-B12 was also shown to be in linkage with HLA-DRw5. This antigen, like HLA-Cw4, was present in the patients to a greater extent than the controls but did not prove to be a statistically significant increase. The analysis of haplotypes in the 11 families studied to date would allow HLA-DRw5 was present in increased frequency in patients with and without iritis; in 71% of those with iritis and 45% of those without. The difference between the two groups was not significant. When present in JRA patients, ANA is found in children with early onset disease with limited joint involvement. Children, mostly female, with a positive ANA and pauciarticular JRA have substantial risk for iritis, with ANA being regarded in this context as a significant marker for the eye disease (6) . The significant association between HLA-DRw5 and ANA in serum, and the high incidence of ANA in those with both iritis and HLA-DRw5 suggests that the HLA-DRw5 association does determine a group at risk not just for pauciarticular JRA but also for those with iritis. Three other groups have recently reported data confirming an association between HLA-DRw5 and pauciarticularonset JRA (18, 19, 20) .
Stastny and Fink (5) have shown an increase in frequency of HLA-DRw8 in their JRA populations, but not of HLA-DRw5, as in this study. The reasons for differences in HLA typing in the two studies on patient populations, with ostensibly the same disease, may include differences in the racial and disease makeup of the patient series. These JRA populations could have some racially determined differences even though both are North American Caucasian. Some regional variation in distribution of HLA is anticipated. Additional differences between these two studies with respect to HLA-DRw5 also derive from selection of the JRA patient population. JRA is presently diagnosed largely by exclusion of other diseases, so that as followup continues, alternative diagnoses become evident. The 45 patients in this study were drawn from a group of over 370 patients with JRA followed for at least 5 yr, and the majority for at least twice that period of time (2) . In the study by Stastny and Fink (5), a larger group of patients were investigated, 106 in all, but at least four different groups of patients were included, as judged clinically and by the HLA typing results, and duration of follow-up was not given.
There are methodological problems in evaluating the HLA-D locus; these we have tried to minimize by including among our antisera a number of antisera of known quality, defined in the Seventh and Eighth International Histocompatibility Workshops (13, 14) . We also took the precaution of excluding sera known to react with the MB or MT antigens, which are believed to be additional specificities expressed on B lymphocytes, each one of which is common to several HLA-DR types (21) .
